AUTEM THERAPEUTICS RAISES $10 MILLION SERIES A-1 FINANCING FOR NOVEL BIOELECTRIC CANCER TREATMENT PLATFORM
June 06, 2022 17:11 ET
|
Autem Therapeutics
Hanover, NH and Sao Paulo, Brazil, June 06, 2022 (GLOBE NEWSWIRE) -- Autem Therapeutics LLC (“Autem Therapeutics” or “the Company”), an emerging oncology therapeutic and bioelectric technology...